August 2021 FDA Recall Drug by Prescription Labs Inc Dba Greenpark
D-0804-2021 - Lack of Assurance of Sterility

This Class II drug recall was voluntarily initiated by Prescription Labs Inc Dba Greenpark on August 18, 2021 for the product Drug. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0804-2021

Reason for Recall
Lack of Assurance of Sterility
Initiated
08-18-2021
Reported
09-22-2021
Quantity
350 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Prescription Labs Inc dba Greenpark
Nationwide within the United States
Spironolactone Ophthalmic Solution 0.005 mg/mL, 15 mL bottles, Rx only, Greenpark Compounding Pharmacy

Batch or Lot Expiration Information

Lot# Lots: 03012021@35; 04132021@10; 05102021@12; 06012021@28; 07012021@25; 03012021@36; 04132021@12; 05102021@11; 06012021@29; 07132021@14; 03152021@9; 06162021@21; 07132021@16; 03152021@10; 06162021@22